The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...

A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...

Many patients take medications to lower blood pressure, blood sugar and cholesterol, which tend to be elevated in people with chronic kidney disease. Patients also sometimes take drugs to ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Millions of Americans take proton pump inhibitors (PPIs) like Prilosec, Nexium, and Prevacid to manage acid reflux, heartburn, and gastroesophageal reflux disease (GERD).

These drugs, called GLP1-RAs (short for glucagon-like peptide-1 receptor agonists), have been found to reduce hospital visits ...

The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

Through sophisticated testing methods, healthcare providers can now identify problems years ... The path to kidney protection extends far beyond taking pills. Research reveals that daily choices ...

Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks ...

has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI) and other ... Researchers Find Cholesterol-Lowering Drugs ...